Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial.
Yoon Jin ChoiYong Chan LeeJung Mogg KimJin Il KimJeong Seop MoonYun Jeong LimGwang Ho BaikByoung-Kwan SonHang Lak LeeKyoung Oh KimNa Young KimKwang Hyun KoHye Kyung JungKi Nam ShimHoon Jai ChunByung-Wook KimHyuk LeeJie-Hyun KimHyunsoo ChungSang Gyun KimJae Young JangPublished in: Gut and liver (2022)
in Korea (ClinicalTrials.gov identifier NCT03317223).